HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Hase Selected Research

Diglycerides

5/2008Effects of a single and short-term ingestion of diacylglycerol on fat oxidation in rats.
1/2008One-year ad libitum consumption of diacylglycerol oil as part of a regular diet results in modest weight loss in comparison with consumption of a triacylglycerol control oil in overweight Japanese subjects.
12/2007Suppressive effects of diacylglycerol oil on postprandial hyperlipidemia in insulin resistance and glucose intolerance.
5/2007Dietary diacylglycerol induces the regression of atherosclerosis in rabbits.
1/2007Effects of phytosterols in diacylglycerol as part of diet therapy on hyperlipidemia in children.
2/2006Diet therapy with diacylglycerol oil delays the progression of renal failure in type 2 diabetic patients with nephropathy.
2/2006Dose-dependent cholesterol-lowering effect of a mayonnaise-type product with a main component of diacylglycerol-containing plant sterol esters.
5/2005Effect of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance.
3/2005Effects of diacylglycerol ingestion on postprandial hyperlipidemia in diabetes.
7/2003Effect of phytosterols in dietary diacylglycerol on atherosclerosis in cholesterol-fed rabbits.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Hase Research Topics

Disease

18Obesity
10/2015 - 08/2002
16Body Weight (Weight, Body)
01/2015 - 10/2002
8Inflammation (Inflammations)
05/2022 - 12/2002
6Hypertension (High Blood Pressure)
09/2013 - 09/2005
4Hyperlipidemias (Hyperlipidemia)
12/2007 - 03/2005
3Neoplasms (Cancer)
08/2018 - 07/2009
3Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2018 - 08/2010
3Type 2 Diabetes Mellitus (MODY)
01/2015 - 12/2007
3Insulin Resistance
01/2015 - 05/2005
3Hypercholesterolemia
10/2013 - 01/2006
2Cardiovascular Diseases (Cardiovascular Disease)
10/2015 - 06/2007
2Hyperglycemia
10/2015 - 08/2010
2Hypertriglyceridemia
08/2011 - 01/2008
2Hyperinsulinism (Hyperinsulinemia)
08/2010 - 05/2009
2Atherosclerosis
05/2007 - 07/2003
1Lactic Acidosis
02/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2018
1Communicable Diseases (Infectious Diseases)
08/2018
1Lentigo (Lentiginosis)
09/2015
1Hyperpigmentation
09/2015
1Frailty
01/2015
1Dental Plaque
06/2013
1Dyslipidemias (Dyslipidemia)
11/2011
1Muscular Atrophy (Muscle Atrophy)
09/2011
1Hypertrophy
05/2008
1Weight Loss (Weight Reduction)
01/2008
1Overweight
01/2008

Drug/Important Bio-Agent (IBA)

12DiglyceridesIBA
05/2008 - 08/2002
9Triglycerides (Triacylglycerol)IBA
09/2012 - 08/2002
6TeaIBA
08/2018 - 01/2005
6Fatty Acids (Saturated Fatty Acids)IBA
09/2015 - 08/2002
6Catechin (Z 7300)IBA
09/2013 - 06/2007
5CholesterolIBA
10/2013 - 07/2003
4CoffeeFDA Link
10/2015 - 09/2005
4Insulin (Novolin)FDA Link
09/2012 - 12/2007
4Phytosterols (Plant Sterols)IBA
01/2007 - 07/2003
36-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
05/2022 - 01/2011
3PolyphenolsIBA
10/2015 - 01/2008
3Glucagon-Like Peptide 1 (GLP 1)IBA
10/2015 - 05/2009
3LipidsIBA
10/2013 - 07/2003
3Starch (Cornstarch)IBA
09/2012 - 03/2010
3Glucose (Dextrose)FDA LinkGeneric
09/2012 - 12/2007
2Dietary Fats (Dietary Fat)IBA
01/2015 - 10/2002
2Resistant StarchIBA
09/2012 - 03/2010
2EnzymesIBA
09/2012 - 11/2006
2HesperidinIBA
05/2008 - 02/2008
2Lipoproteins (Lipoprotein)IBA
12/2007 - 01/2007
2EstersIBA
02/2006 - 01/2006
1ElementsIBA
05/2022
1RE1-silencing transcription factorIBA
05/2022
1Phenformin (Fenformin)IBA
02/2020
1Pharmaceutical PreparationsIBA
02/2020
1perillic acidIBA
01/2018
1perillaldehydeIBA
01/2018
1Receptor for Advanced Glycation End ProductsIBA
03/2016
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2015
1ginger extractIBA
10/2015
1Transcription Factors (Transcription Factor)IBA
09/2015
1Endothelin B ReceptorIBA
09/2015
1Endothelin-1 (Endothelin 1)IBA
09/2015
1Cytokine Receptors (Cytokine Receptor)IBA
09/2015
1Melanins (Melanin)IBA
09/2015
1milk fat globuleIBA
01/2015
1hesperetinIBA
09/2013
1glucosyl hesperidinIBA
09/2013
1AntioxidantsIBA
09/2013
116S Ribosomal RNAIBA
06/2013
1Messenger RNA (mRNA)IBA
01/2013
1Thromboxane A2 (A2, Thromboxane)IBA
01/2013
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2013
1Phosphates (Orthophosphate)IBA
09/2012
1GlycogenIBA
09/2012
1Lactic Acid (Lactate)FDA LinkGeneric
09/2012
14-(4-sulfophenylazo)-2-mercuriphenol (SAMP)IBA
12/2011
1FructoseIBA
11/2011
1Diacylglycerol O-AcyltransferaseIBA
08/2011
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2010
1nootkatoneIBA
08/2010
1AMP-Activated Protein KinasesIBA
08/2010
1Sucrose (Saccharose)IBA
08/2010
1CatecholaminesIBA
12/2009
1Biological ProductsIBA
07/2009
1IncretinsIBA
05/2009
1Peptides (Polypeptides)IBA
05/2009
1Hormones (Hormone)IBA
05/2009
1Proteins (Proteins, Gene)FDA Link
03/2009
1Therapeutic UsesIBA
02/2009
1Hemoglobin AIBA
02/2009
1SolutionsIBA
01/2009
1NADP (NADPH)IBA
05/2008
1Oxidoreductases (Dehydrogenase)IBA
05/2008
1hydroxyhydroquinone (hydroxyquinol)IBA
01/2008
13-nitrotyrosineIBA
01/2008
1AcidsIBA
01/2008
1Fish OilsIBA
12/2007

Therapy/Procedure

2Diet Therapy (Therapy, Diet)
01/2007 - 02/2006
1Fat-Restricted Diet (Diet, Fat Restricted)
01/2015
1Oral Administration
07/2009
1Glycemic Control
02/2009
1Therapeutics
02/2009